Approach to the asymptomatic patients with Brugada syndrome

Indian Pacing and Electrophysiology Journal

Volumn 7, Issue 2, 2007, Pages 73-76

  Takagi, Masahiko ^a   Tatsumi, Hiroaki ^a   Yoshiyama, Minoru ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Asymptomatic; Brugada syndrome; Risk stratification; Sudden cardiac death

Indexed keywords

CILOSTAZOL; ISOPRENALINE; QUINIDINE; TEDISAMIL;

BRUGADA SYNDROME; CARDIOVASCULAR RISK; CLINICAL FEATURE; DEFIBRILLATOR; EDITORIAL; ELECTROCARDIOGRAPHY; FAMILY HISTORY; HEART ARREST; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION; SUDDEN DEATH; SYNCOPE; TREATMENT INDICATION;

EID: 34547908857     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. Brugada P, Brugada J: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992;20:1391-1396.
2. Priori SG, Napolitano C, Gasparini M, et al.: Natural history of Brugada syndrome: insight for risk stratification and management. Circulation 2002;105:1342-1347.
3. Brugada J, Brugada R, Antzelevitch C, et al.: Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-78.
4. Brugada J, Brugada R, Brugada P: Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108-3092-3096.
5. Antzelevitch C, Brugada P, Borggrefe M, et al.: Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-670.
6. Eckardt L, Probst V, Smits JPP, et al.: Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005;111:257-263.
7. Matsuo K, Akahoshi M, Nakashima E, et al.: The prevalence incidence and prognostic value of the Brugada-type electrocardiogram: A population-based study of four decades. J Am Coll Cardiol 2001;38:765-770.
8. Atarashi H, Ogawa S, Harumi K, et al.: Three-year follow-up of patients with right bundle branch block and ST-segment elevation in right precordial leads: Japanese Registry of Brugada Syndrome. Idiopathic Ventricular Fibrillation Investigators. J Am Coll Cardiol 2001;37:1916-1920.
9. Miyasaka Y, Tsuji H, Yamada K, et al.: Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol 2001;38:771-774.
10. Atarashi H, Ogawa S: Idiopathic Ventricular Fibrillation Investigator: New ECG criteria for high-risk Brugada syndrome. Circ J, 2003;67:8-10.
11. Ajiro Y, Hagiwara N, Kasanuki H: Assessment of markers for identifying patients at risk for life-threatening arrhythmic events in Brugada syndrome. J Cardiovasc Electrophysiol 2005;16:45-51.
12. Ikeda T, Sakurada H, Sakabe K, et al.: Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol 2001;37:1628-1634.
13. Mizumaki K, Fujiki A, Tsuneda T, et al.: Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome. J Cardiovasc Electrophysiol 2004;15:667-673.
14. Ikeda T, Abe A, Yasu S, et al.: The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome. J Cardiovasc Electrophysiol 2006; 17:602-607.
15. Tatsumi H, Takagi M, Nakagawa E, et al.: Risk stratification in patients with Brugada syndrome: Analysis of daily fluctuation in 12-lead electrocardiogram and signal-averaged electrocardiogram. J Cardiovasc Electrophysiol 2006;17:705-711.
16. Gehi AK, Duong TD, Metz LD, et al.: Risk stratification of individuals with the Brugada Electrocardiogram: A meta-analysis. J. Cardiovasc Electrophysiol 2006;17:577-583.
17. Priori SG, Napolitano C: Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005;112:285-291.
18. Belhassen B, Viskin S, Fish R, et al.: Effects of electrophysiologic-guided therapy with Class 1A antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 1999;10:1301.
19. Belhassen B, Viskin S, Antzelevitch C.:The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option? Pacing Clin Electrophysiol 2002;25:1634.
20. Alings M, Dekker L, Sadee A, et al.: Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol 2001;24:1420-1422.
21. Antzelevitch C.:The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001;12:268-272.
22. Tanaka H, Kinoshita 0, Uchikawa S, et al.: Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome. Pacing Clin Electrophysiol 2001;24:1293-1294.
23. Tsuchiya T, Ashikaga K, Honda T, et al.: Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002;13:698-701.